Williams B T, Schröder R, O'Brien P Q. "Method for the Synthesis of Topiroxostat Impurity 56" [P]. US Patent, US 11618878 B2, 2023-08-10.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 托吡司特杂质56 in Pharmaceutical Formulations". Chemosphere, 2025, 366, (10), 7499-7514.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 托吡司特杂质56 as an Impurity". Anal. Chim. Acta, 2010, 1393, (4), 8284-8293.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Topiroxostat Impurity 56 Using HRMS and NMR". Biomed. Chromatogr., 2023, 2079, (5), 8525-8528.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate 托吡司特杂质56 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2012, 345, 5078-5094.